Director of Decibel Therapeutics, Inc. (NASDAQ:DBTX), Glaxosmithkline Plc, buys 150,000 shares worth $2,700,000

According to Decibel Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 19 04:50 PM, company Director, Glaxosmithkline Plc disclosed buying 150,000 shares at a cost of $18.00. At the time of this transaction (Feb 17), this trade was worth $2,700,000 in total. As of Feb 17, Glaxosmithkline Plc now owns 1,183,663 shares in total worth about $22,548,780.150000002.

For the last few recent trades made by Decibel Therapeutics, Inc. (NASDAQ:DBTX) Director, Glaxosmithkline Plc, we have the following information:

Posted by George Daniels on Friday February 19 2021, 10:35 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0